Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 19/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31488875 | 0.90 | NAMPT (0.57) | NAMPTCYP3A4CYP2C9NPC1MAPT | |
| SCHEMBL31488930 | 0.89 | NAMPT (0.71) | NAMPTCYP3A4CYP2C9NPC1MAPT | |
| SCHEMBL31488961 | 0.88 | NAMPT (0.78) | NAMPTCYP3A4CYP2C9NPC1MAPT | |
| SCHEMBL31488948 | 0.87 | NAMPT (0.77) | NAMPTCYP3A4CYP2C9 | |
| SCHEMBL31489055 | 0.87 | NAMPT (0.72) | NAMPTCYP3A4CYP2C9NPC1MAPT | |
| SCHEMBL31489012 | 0.87 | NAMPT (0.76) | NAMPTCYP3A4CYP2C9NPC1MAPT | |
| SCHEMBL31488848 | 0.87 | NAMPT (0.71) | NAMPTCYP3A4CYP2C9NPC1MAPT | |
| SCHEMBL31488884 | 0.86 | NAMPT (0.73) | NAMPTCYP3A4CYP2C9 | |
| SCHEMBL31488819 | 0.85 | NAMPT (0.51) | NAMPTCYP3A4CYP2C9 | |
| SCHEMBL31488975 | 0.83 | NAMPT (0.63) | NAMPTCYP3A4CYP2C9NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072437-A1 | HETEROARYL COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | ALPHINA THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |